Region · Healthcare markets

North America healthcare markets

178 reports across 5 categories, with market size and growth to 2033.

Fastest-growing in North America

2023–2033 CAGR · estimates

  1. 1Blockchain in Genomics 37.3% $1.1 Bn → $26.5 Bn
  2. 2Artificial Intelligence (AI) Machine Learning(ML) in Healthcare 37% $950 Mn → $22.1 Bn
  3. 3Artificial Intelligence (AI) in Medicine 36.5% $4.2 Bn → $93.2 Bn
  4. 4Digital Biomarkers 34.5% $2.2 Bn → $42.6 Bn
  5. 5Artificial Intelligence (AI) in Remote Patient Monitoring 29.4% $450 Mn → $5.9 Bn
  6. 6Blockchain-as-a-Service 28.3% $1.1 Bn → $12.7 Bn
  7. 7Artificial Intelligence (AI) in Radiology 27.6% $300 Mn → $3.4 Bn
  8. 8Connected Healthcare Market 26.1% $29.4 Bn → $298.9 Bn

By category

Biggest markets in North America

Market size in 2023

  1. 1Hospitals and Health Systems $2,178.2 Bn
  2. 2Healthcare IT $241.3 Bn
  3. 3Nutritional Supplements $192.5 Bn
  4. 4Home Healthcare $181.1 Bn
  5. 5Dietary Supplements $154 Bn
  6. 6Healthcare Information System $145.1 Bn
  7. 7Functional Food $142.5 Bn
  8. 8IoT in Healthcare $90.3 Bn

Most clinical trials in North America

Active trials (recruiting, about to start or running) in US, Canada

  1. 1Oncology/Cancer Drugs 9,646
  2. 2Cell Based Immunotherapy 8,825
  3. 3Ambulatory Surgery Center 5,285
  4. 4Point of Care Diagnostics 3,895
  5. 5BCAA Supplement 2,825
  6. 6Home Healthcare 2,519
  7. 7Dermatology Diagnostic 2,114
  8. 8Brain Imaging, Biomarkers and NeuroInformatics 1,908

Health in North America: WHO figures

Latest figure for each country we report on in North America (WHO)
MeasureUSCanada
Diabetes (adults) % of adults 12.5 20226.8 2022
Obesity (adults) % of adults 41.0 202426.0 2024
High blood pressure (ages 30–79) % of adults 30–79 31.6 201922.1 2019
Anaemia in women 15–49 % of women 15.0 202314.0 2023
Universal health coverage index index (0–100) 88 202392 2023
Road traffic deaths per 100,000 people 18.4 20235.3 2023
Healthy life expectancy years 64.6 202367.9 2023
Early deaths from long-term diseases % 12.6 20239.6 2023
Tobacco use (adults) % of adults 15.2 202510.8 2025
Not active enough (adults) % of adults 33.7 202237.2 2022
Alcohol drunk per person litres of pure alcohol (15+) 9.6 20249.2 2024
Fine dust in the air (PM2.5) µg per m³ 9.8 20238.8 2023

North America: People and health spending

Latest figure for each country we report on in North America (World Bank)
MeasureUSCanada
Population people 341.8 million 202541.7 million 2025
Life expectancy at birth years 78.9 202482.1 2024
People aged 65 and over % of people 18.4 202520.3 2025
Health spending per person US$ per person 13,473 20236,378 2024
Health spending (% of GDP) % of GDP 16.7 202311.3 2024
Out-of-pocket spending % of health spending 10.9 202315.3 2024
Doctors per 1,000 people 3.68 20222.82 2023
Nurses and midwives per 1,000 people 13.38 202211.26 2023
Hospital beds per 1,000 people 2.68 20222.54 2022

Companies most covered in North America

Medtronic30 reports Johnson & Johnson27 reports Abbott Laboratories25 reports Pfizer Inc.24 reports GE Healthcare23 reports Siemens Healthineers21 reports Novartis AG19 reports Philips Healthcare16 reports Bayer AG15 reports Merck & Co., Inc.15 reports Sanofi15 reports IBM Watson Health13 reports

All 178 North America markets

Each market name opens its North America report. To compare one market across every country, see market statistics.

Digital Health 41 markets
Digital Health markets in North America
Market20232033 (projected)CAGR Active trials
3D Laparoscopy Imaging Systems $1.6 Bn $2.8 Bn 5.7% 4
3D Printed Implants $1.8 Bn $5.8 Bn 12.5% 11
3D Printing in Medical Application $1.2 Bn $7 Bn 19.3% 58
Artificial Intelligence (AI) in Drugs Discovery $300 Mn $2.8 Bn 25.1% 127
Artificial Intelligence (AI) in Healthcare – – – 725
Artificial Intelligence (AI) in Life Sciences $1.1 Bn $10.8 Bn 25.7% 374
Artificial Intelligence (AI) in Medical Imaging $450 Mn $3.9 Bn 24.2% 86
Artificial Intelligence (AI) in Medicine $4.2 Bn $93.2 Bn 36.5% 725
Artificial Intelligence (AI) in Pharma – – – 127
Artificial Intelligence (AI) in Radiology $300 Mn $3.4 Bn 27.6% 29
Artificial Intelligence (AI) in Remote Patient Monitoring $450 Mn $5.9 Bn 29.4% 24
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare $950 Mn $22.1 Bn 37% 725
Blockchain in Genomics $1.1 Bn $26.5 Bn 37.3% 0
Blockchain-as-a-Service $1.1 Bn $12.7 Bn 28.3% 0
Brain Imaging, Biomarkers and NeuroInformatics $340 Mn $489 Mn 3.7% 1,908
Brain PET-MRI Systems $170 Mn $290 Mn 5.5% 924
Clinical Alarm Management $870 Mn $1.1 Bn 2.3% 49
Clinical Data Management Systems $1.3 Bn $3.5 Bn 10.9% 97
Connected Healthcare Market $29.4 Bn $298.9 Bn 26.1% 797
Decentralized Clinical Trials(DCTs) $820 Mn $3 Bn 13.8% 1,096
Dental 3D Printing $1.7 Bn $10.1 Bn 19.5% 8
Dental CAD/CAM $1.7 Bn $3.9 Bn 9% 8
Digital Biomarkers $2.2 Bn $42.6 Bn 34.5% 224
Digital diabetes care $6.4 Bn $34.4 Bn 18.3% 383
Digital Pathology Systems $600 Mn $2 Bn 12.7% 630
Digital Therapeutics $3.4 Bn $21.1 Bn 20% 1,249
Digital Twin $850 Mn $6.9 Bn 23.3% 12
Digital X-ray $8.7 Bn $13.9 Bn 4.8% 1,457
Electronic Health Record $18.1 Bn $24.7 Bn 3.2% 1,110
Healthcare Information System $145.1 Bn $645.6 Bn 16.1% 3,157
Healthcare IT $241.3 Bn $710.1 Bn 11.4% 474
Home Healthcare $181.1 Bn $352.8 Bn 6.9% 2,519
Internet Of Things In Healthcare $49.8 Bn $219.7 Bn 16% 23
IoT in Healthcare $90.3 Bn $401.8 Bn 16.1% 23
Long-term Care Software $1.8 Bn $5.2 Bn 11.6% 159
Mental Health Apps $2.8 Bn $16.9 Bn 19.7% 313
Pathology Imaging Systems $810 Mn $2.3 Bn 10.9% 630
Point of Care Diagnostics $22.7 Bn $42.2 Bn 6.4% 3,895
Remote Medication Management $1.9 Bn $8.6 Bn 16% 398
Remote Patient Monitoring $790 Mn $3.7 Bn 16.8% 403
Werable Healthcare Devices $16.3 Bn $91.4 Bn 18.8% 686
Healthcare Services 24 markets
Healthcare Services markets in North America
Market20232033 (projected)CAGR Active trials
Alopecia areata – – – 79
Alzheimers Dignostic $1.1 Bn $1.9 Bn 5.9% 470
Ambulance Service $15.7 Bn $28.3 Bn 6.1% 429
Ambulatory Surgery Center $20 Bn $32.9 Bn 5.1% 5,285
Antimicrobial Susceptibility Testing – – – 27
Bioinformatics $6.1 Bn $21.5 Bn 13.4% 53
Biomaterial Wound Dressing $4.1 Bn $7.1 Bn 5.7% 110
Blood Gas and Electrolyte Analyzers $1.4 Bn $2.4 Bn 5.4% 268
Bone Cancer Diagnostic $550 Mn $1 Bn 6.4% 689
Brain Cancer Diagnostic $750 Mn $2.5 Bn 12.6% 953
Breast Cancer Diagnostic $2.1 Bn $4 Bn 6.8% 1,758
Clinical Laboratory Service – – – 3,698
Dental Care Service – – – 56
Dental Imaging $1.7 Bn $3.3 Bn 6.9% 140
Dermatology Diagnostic $13 Bn $34.3 Bn 10.2% 2,114
Fertility Service $10.5 Bn $17.3 Bn 5.1% 108
Healthcare Electronic Data Interchange (EDI) $2 Bn $4.5 Bn 8.4% 72
Healthcare In Vitro Diagnostic $41.8 Bn $55 Bn 2.8% 83
Hospitals and Health Systems $2,178.2 Bn $3,415.2 Bn 4.6% 14,515
Medical Billing $2.3 Bn $6.1 Bn 10.4% 47
Medical Tourism $37.1 Bn $107.3 Bn 11.2% 1
Nursing Education $5.2 Bn $10.2 Bn 7.1% 152
Patient Support Programs (PSP) $8.6 Bn $25.9 Bn 14.8% 1,189
Point Of Care (PoC) Molecular Diagnostic $9.4 Bn $20.8 Bn 8.3% 277
Medical Devices 27 markets
Medical Devices markets in North America
Market20232033 (projected)CAGR Active trials
Acute Care Needleless Connectors $245 Mn $460 Mn 6.5% 1
Advanced Bipolar Direct Energy Devices $1.6 Bn $3.3 Bn 7.7% 242
Aesthetic Lasers and Energy Devices $810 Mn $2.3 Bn 11.1% 70
Air Ambulance Life Support Solutions $2.2 Bn $4.9 Bn 8.1% 7
Airway Management Devices $1 Bn $1.5 Bn 4.2% 391
Anastomosis Devices $1.6 Bn $2.8 Bn 5.8% 115
Anesthesia & Respiratory Devices $14.4 Bn $32.4 Bn 8.5% 145
Anesthesia Monitoring Devices $1.3 Bn $3.9 Bn 11.5% 76
Angiography Devices $6.2 Bn $10.4 Bn 5.3% 475
Angioplasty Balloons $2 Bn $2.7 Bn 2.8% 55
Anti-Snoring Devices $625 Mn $1.3 Bn 7.8% 108
Apheresis Equipments $1.3 Bn $2.1 Bn 5.2% 248
Arrhythmia Monitoring Devices $3 Bn $4.7 Bn 4.5% 101
Assisted Walking Aids $1.2 Bn $1.8 Bn 4.5% 863
Audiology Devices $3.9 Bn $6.6 Bn 5.4% 135
Defibrillator $8.9 Bn $14.3 Bn 4.9% 138
Dental Articulators $195 Mn $330 Mn 5.4% 2,484
Dental Caries Detectors $185 Mn $516 Mn 10.8% 19
Dental Diagnostic and Surgical Equipments $6 Bn $10.8 Bn 6.1% 1,369
Dental X-Ray Equipments $875 Mn $1.6 Bn 6.2% 110
Diabetes Care Devices $21.3 Bn $34.4 Bn 4.9% 348
Digital Diabetes Management – – – 383
Direct Energy Medical Devices $5.5 Bn $8.2 Bn 4% 482
Disposable Surgical Devices $4.5 Bn $8.3 Bn 6.3% 5,848
Insulin Delivery Devices $7.9 Bn $13.6 Bn 5.5% 158
Insulin Patch Pumps $445 Mn $1.3 Bn 11% 8
Rehabilitation Equipments $10 Bn $16.5 Bn 5.1% 686
OTC & Nutraceuticals 48 markets
OTC & Nutraceuticals markets in North America
Market20232033 (projected)CAGR Active trials
Adaptogens $4.1 Bn $8.3 Bn 7.5% 14
Amino Acid – – – 138
Anthelmintic Drug – – – 7
Antioxidants – – – 40
Antipyretics OTC – – – 1
BCAA Supplement $700 Mn $1.2 Bn 5.7% 2,825
Beauty Supplements $2.1 Bn $4.5 Bn 8.2% 117
Biotin Supplement $200 Mn $296 Mn 4% 12
Bone & Joint Health Supplements $6 Bn $10.2 Bn 5.4% 9
Calcium Supplements $1.3 Bn $2 Bn 5% 69
Cannabidiol (CBD) Supplements $2.7 Bn $11.5 Bn 15.8% 150
Cardiovascular Health Supplements $3.4 Bn $5.4 Bn 4.7% 107
Clinical Nutrition $14.3 Bn $25.8 Bn 6.1% 207
Coenzyme Q10 $250 Mn $540 Mn 8% 23
Collagen Supplements $1.1 Bn $1.8 Bn 5.1% 41
Creatine $300 Mn $503 Mn 5.3% 145
Dietary Supplements $154 Bn $255.7 Bn 5.2% 1,217
Eye Health Supplements $1.6 Bn $2.6 Bn 5.2% 18
Functional Food $142.5 Bn $248.1 Bn 5.7% 866
Hair Growth Supplements $900 Mn $1.7 Bn 6.3% 3
Herbal Supplements $41 Bn $77.7 Bn 6.6% 38
Immune Health Supplement – – – 214
Iron Supplement $1 Bn $1.7 Bn 5.5% 71
Men's Health Supplements $9.1 Bn $15.9 Bn 5.8% 94
Mood and Stress Supplements $5.3 Bn $10.4 Bn 7.1% 68
Nutritional Supplements $192.5 Bn $338.3 Bn 5.8% 1,043
Omega 3 Fatty Acid $2.1 Bn $3.8 Bn 6.4% 162
Oncology Nutrition $1.1 Bn $1.9 Bn 6.3% 540
Osteoporosis Supplements $1.6 Bn $2.6 Bn 5.5% 14
Over The Counter (OTC) Analgesics $11 Bn $13.9 Bn 2.4% 137
Over The Counter (OTC) Antifungal $1.3 Bn $1.6 Bn 2.8% 2
Over The Counter (OTC) Consumer $75.5 Bn $113.9 Bn 4.2% 163
Over The Counter (OTC) Drugs $89 Bn $128 Bn 3.7% 163
Over The Counter (OTC) Gastrointestinal Drugs $2.8 Bn $3.7 Bn 2.9% 97
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs $7.3 Bn $9.8 Bn 3.1% 149
Over The Counter (OTC) Ophthalmic Drugs $1.8 Bn $2.5 Bn 3.5% 102
Over The Counter (OTC) Pharmaceuticals $89 Bn $128 Bn 3.7% 163
Over The Counter (OTC) Sleep Aid Products $2.7 Bn $3.6 Bn 3% 23
Over The Counter (OTC) Vitamins and Minerals $16 Bn $24.8 Bn 4.5% 160
Plant-Based Supplements $6.2 Bn $12.1 Bn 7% 41
Prebiotics $4.1 Bn $11.3 Bn 10.8% 97
Probiotic Supplements for Gut Health $3.1 Bn $5.6 Bn 6.2% 103
Protein Supplement $10 Bn $18.6 Bn 6.4% 307
Sports Nutrition $26 Bn $50.7 Bn 6.9% 52
Vitamin B12(Cobalamin) $150 Mn $233 Mn 4.5% 44
Vitamin D Supplements – – – 188
Weight Management Supplement – – – 54
Women's Health Supplements $10 Bn $17.6 Bn 5.8% 296
Pharmaceuticals 38 markets
Pharmaceuticals markets in North America
Market20232033 (projected)CAGR Active trials
Abuse Deterrent Opioids – – – 0
Alexipharmic Drugs – – – 97
Alopecia Drugs (Hair Loss) – – – 82
Alzheimer Drugs $2.5 Bn $4.4 Bn 5.8% 472
Aminoglycosides – – – 336
Anemia Drugs – – – 398
Anti-Aging $44.1 Bn $87.6 Bn 7.1% 1,129
Anti-Depressants Drugs $9 Bn $10.7 Bn 1.7% 1,095
Anti-Nerve Growth Factor – – – 194
Anti-Venom – – – 1
Anticoagulants – – – 197
Antithrombotic Drugs – – – 78
Artificial Skin $1.3 Bn $2 Bn 4.8% 16
Asthma & COPD Drugs $24.8 Bn $33.3 Bn 3% 381
Atherosclerosis Drugs – – – 216
Atopic Dermatitis Drugs $5.6 Bn $16.2 Bn 11.2% 117
Autologous Matrix-induced Chondrogenesis – – – 27
Axial Spondyloarthritis (axSpA) – – – 23
Biological Safety Testing – – – 649
Biosimilar Monoclonal Antibodies – – – 355
Biosimilars $18.5 Bn $157.3 Bn 23.9% 355
Blood Plasma – – – 4,214
Bone Marrow Aspirate Concentrates – – – 176
Burn Care – – – 77
Burn Ointment – – – 14
Cancer Supportive Care Drugs $12.4 Bn $17.8 Bn 3.7% 1,873
Cannabidiol (CBD) $11 Bn $47.8 Bn 15.8% 150
Cannabis $17 Bn $55 Bn 12.5% 389
Cell Based Immunotherapy $8.3 Bn $60.6 Bn 22% 8,825
Contraceptives Drugs $12.6 Bn $22.1 Bn 5.8% 53
Cord Blood Banking Service $950 Mn $1.6 Bn 5.5% 465
Diabetes Management $39 Bn $70.5 Bn 6.1% 1,374
Diabetic Retinopathy Drugs $5.4 Bn $8.8 Bn 5% 80
Epilepsy Drugs $4.8 Bn $6.1 Bn 2.5% 235
Gastroesophageal Reflux Disease (GERD) Drugs $2.6 Bn $2.9 Bn 1.1% 68
Gastrointestinal Drugs $27 Bn $38.5 Bn 3.6% 3,062
HIV Drugs $15 Bn $24 Bn 4.8% 526
Oncology/Cancer Drugs $88.5 Bn $180.7 Bn 7.4% 9,646

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

Consult us Planning for North America? We can size your market, compare regions and name the key companies. Talk to us Browse the reports All 178 North America reports, with a free sample of each. See reports See the public data Compare North America with the world on 94 free health measures. Open the Public Health Dashboard

All 178 North America reports Other countries